General Information of Drug (ID:
DR5572) |
Drug Name |
Sarpogrelate
|
Synonyms |
Sarpogrelate [INN]; Sarpogrelate (INN); Butanedioic acid, mono[2-(dimethylamino)-1-[[2-[2-(3-methoxyphenyl)ethyl]phenoxy]methyl]ethyl] ester; 4-[1-(dimethylamino)-3-[2-[2-(3-methoxyphenyl)ethyl]phenoxy]propan-2-yl]oxy-4-oxobutanoic acid; 4-{[1-(dimethylamino)-3-{2-[2-(3-methoxyphenyl)ethyl]phenoxy}propan-2-yl]oxy}-4-oxobutanoic acid
|
Indication |
Diabetic complication
[ICD11: 5A2Y]
|
Approved
|
[1]
|
Structure |
|
|
3D MOL
|
2D MOL
|
Pharmaceutical Properties |
Molecular Weight |
429.5 |
Topological Polar Surface Area |
85.3 |
Heavy Atom Count |
31 |
Rotatable Bond Count |
14 |
Hydrogen Bond Donor Count |
1 |
Hydrogen Bond Acceptor Count |
7 |
Cross-matching ID |
- PubChem CID
- 5160
- ChEBI ID
-
- CAS Number
-
- TTD Drug ID
- D0G6VL
- Formula
- C24H31NO6
- Canonical SMILES
- CN(C)CC(COC1=CC=CC=C1CCC2=CC(=CC=C2)OC)OC(=O)CCC(=O)O
- InChI
- InChI=1S/C24H31NO6/c1-25(2)16-21(31-24(28)14-13-23(26)27)17-30-22-10-5-4-8-19(22)12-11-18-7-6-9-20(15-18)29-3/h4-10,15,21H,11-14,16-17H2,1-3H3,(H,26,27)
- InChIKey
- FFYNAVGJSYHHFO-UHFFFAOYSA-N
|
|
|
|
|
|
|
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.